Navigation Links
Kinerase Wins Allure Best of Beauty Award for 2nd Consecutive Year
Date:9/27/2011

NEW YORK, Sept. 27, 2011 /PRNewswire/ -- Kinerase, an icon of scientific skincare development, continues to provide award winning beauty for the second year in a row.  The Kinerase Restructure Firming Eye Cream has been named a winner in the 2011 Allure Best of Beauty Awards, appearing in the magazine's October 2011 issue.

(Photo:  http://photos.prnewswire.com/prnh/20110927/NY75304 )

This year, over 236 beauty products were chosen as winners across a number of categories, including skincare, hair care, cosmetics and tools. Winners were selected by Allure's editors and other industry leaders, trying thousands of products before awarding the top honors. The winning products -- which will boast the coveted Allure Best of Beauty seal of approval -- were honored by Allure at an awards ceremony Thursday night (9.15.11) at New York's Jazz at Lincoln Center.

KINERASE RESTRUCTURE FIRMING EYE CREAM:

A departure from the typical firming products, Kinerase Restructure Firming Eye Cream ($59 available at Ulta, Ulta.com, Nordstrom or Kinerase.com) visibly transforms skin by targeting elastin protein coils to lift and tone the contours of the eye area.

This luxurious Kinerase eye firming regimen combines the plant extract LOXL Stimulator, potent, clinically proven antioxidants and .15% Kinetin to improve skin elasticity and tone, tighten, and restructure for a more lifted look.  Restructure Firming Eye Cream also reduces the appearance of expression wrinkles and deeply moisturizes for firmer, smoother, more youthful-looking skin.  

About Kinerase

KINERASE® skincare provides powerful anti-aging efficacy, delivering clinically-proven visible results in gentle skin-caring formulations. The power behind Kinerase is Kinetin (N6-furfuryladenine), a plant-based antioxidant whose anti-aging properties were discovered when scientists found that it prevented plant leaves from drying out and withering. With Kinerase, indulge the luxury of skincare science to reveal youthful, radiant skin.  For more information visit http://www.kinerase.com or https://www.facebook.com/#!/Kinerase

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.


'/>"/>
SOURCE Kinerase
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kinerase® Introduces "Change Your Skin, Change Your Life" Charity Campaign
2. Pelleve(TM) Wrinkle Treatment System Featured On Beauty Spaces TV Show
3. FDA: Potentially Harmful Stimulant Found in Slimming Beauty Capsules
4. CVS/pharmacy Launches ExtraCare Beauty Club
5. TRIA Beauty Leading the Charge in Bridging Gap Between Science and Skin Health
6. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
7. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
8. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
9. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
10. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... YORK , Feb. 23, 2017  This report ... Thousand by the following Products: Intermediates, ... in the report include Pharmaceuticals, and Agrochemicals. The report ... Japan , Europe , and ... for the period 2015 through 2022. Also, a six-year ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
(Date:2/23/2017)... -- Genesis Healthcare Services has merged with Hospice Cloud, a ... Bill Monast , President and CEO of Hospice Cloud ... , executives with Home Health Depot, Inc., the parent ... This acquisition helps Hospice Cloud maintain its position as ... equipment (DME) solutions for the hospice industry. Nathan ...
Breaking Medicine Technology:
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... ODH, Inc.™ ... Care Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s ... PerformCARE to use behavioral health analytics to improve Medicaid population health management. , ODH ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... newly designed TaskMate Go. Core benefits and advantages built into the home office ... stylish, functional look and feel. Ability to gain the benefits embedded in the ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... ... 2017 , ... With millions of Americans and people worldwide ... all are aware of our options and are empowered with strength and information ... of its newest edition of "Vision and Hearing" in USA Today, that will ...
(Date:2/24/2017)... ... February 24, 2017 , ... The California State University Institute for Palliative ... in or interested in palliative care education and research. The Symposium, “Innovate. Investigate. ... County San Diego on Sept. 28 and 29, 2017, on the campus of California ...
Breaking Medicine News(10 mins):